Novel triazole compounds with a dioxane ring were synthesized. Condensation of the diol precursor 10 with various aromatic aldehydes 11-13 under acidic conditions afforded a series of dioxane-triazole compounds 14-16. The antifungal activities of the compounds 14-16 were evaluated in vivo in mice infection models against Candida and Aspergillus species. High activities were seen for the derivatives with one or two double bond(s) and an aromatic ring substituted with an electron-withdrawing group in the side chain. Among the derivatives, R-102557 (16R: Ar‫-3,3,2,2(-4؍‬tetrafluoropropoxy)phenyl) showed excellent in vivo activities against Candida, Aspergillus and Cryptococcus species. It also showed high tolerance in a preliminary toxicity study in rats.
There have been increasing demands for antifungal agents that are effective against systemic mycosis. 1) We are surrounded by fungi, and it is thanks to our immune system that our bodies are not invaded by fungi. But once our immune system becomes deficient or suppressed, as it does in AIDS patients and in those that have received cancer chemotherapy or organ transplants, then we become highly susceptible to such fungal infection. In many cases it is not the AIDS or cancer itself but the mycosis that is lethal to these patients.
Attention has been paid to triazole derivatives 2) because of their generally broad antifungal spectrum and low toxicity. Triazole derivatives displace lanosterol from lanosterol 14-demethylase (14DM), a cytochrome P450-dependent enzyme, and block the biosynthesis of an essential component of the fungal cell membrane, ergosterol.
3) Fluconazole 4) (1) has relatively low antifungal activity in vitro, but it is watersoluble, and has excellent pharmacokinetic properties. It is effective against candidiasis after both oral administration and injection. However, its activity against Aspergillus seems limited. Itraconazole 5) (Ϯ)- (2) has an excellent and broader antifungal spectrum. Newer triazole agents such as voriconazole 6) (3), Sch56592 7) (4) and ER-30346 8) (BMS-207147) (5) , are active against Aspergillus and currently under clinical trials.
In our continuing program 9) aimed at finding a new triazole antifungal agent, we designed a series of dioxane-triazole compounds depicted by the general formula I (Chart 1). We presumed that the left-half portion of the molecule, shown in the box, is essential to the high antifungal activity. It is a common substructure seen in many other triazole antifungals. The 1,3-dioxane ring was introduced in the expectation that: 1) Since acetal moieties will make a molecule more hydrophilic and water-soluble than simple hydrocarbon moieties, the compound could become more available orally and would be more easily delivered to the target fungal enzyme; 2) since many other triazole antifungal agents have heteroatoms at the corresponding part of the molecule, complementary structure of the target enzyme would be implied; 3) a 2,5-substituted-1,3-dioxane ring would not create a chiral center and would generate cis and trans isomers only; and 4) a variety of aldehydes should be available as the side chain precursor. The sulfur atom was incorporated in the 3-position because the molecule could readily be prepared from the known epoxide 8.
9a,b,e, 10) The methyl group at the 3-position mimics the 13b-methyl group of lanosterol.
9e, f ) The two fluorine atoms in the benzene ring in the left half of the molecule aim at strengthening the antifungal activity. 4b,10c) In this paper, we will present our recent findings on synthesis and antifungal activities of the compounds I. Chemistry In order to prepare a variety of derivatives I in an efficient manner, the diol 10 was planned as a pivotal precursor. Preparation of the diol 10 was accomplished as follows (Chart 2). The known tosylate 6 11) was heated with potassium thioacetate in N,N-dimethylformamide (DMF) to give the thioester 7 in 43% yield. Then, the optically active known epoxide 8 9a,b,e,10) was treated with the thioester 7 in the presence of sodium methoxide to afford the thioether 9 in 91% yield. The benzylidene protecting group was removed by acid treatment to furnish 10 in 88% yield.
Synthesis and Antifungal Activities of R-102557 and Related Dioxane-Triazole Derivatives
The diol 10 was coupled with a variety of aldehydes 11, 12, and 13 (Chart 3). The reaction was driven by stirring a solution of a mixture of diol 10 and each aldehyde 11-13 in dichloromethane in the presence of p-toluenesulfonic acid and molecular sieves 4A. The trans dioxane isomers 14, 15, and 16 were predominantly produced, and easily separated from the cis isomers 14, 15, and 16 by column chromatography. The stereochemistry was elucidated by 1 H-NMR spectrum. The trans isomers 14, 15, and 16, showed the characteristic signal for the methine proton at the 5-position of the 1,3-dioxane ring with a large coupling constant (triplet of triplets, Jϭca. 11, 5 Hz) . An analogous signal pattern was observed for the above-mentioned trans thioether 9. In contrast, the cis isomers 14, 15, and 16 showed small coupling constants (triplet-like, Jϭca. 2 Hz) . These data indicate that the methine protons in the isomers 14, 15, and 16 are axial and those in the isomers 14, 15, and 16 are equatorial. Therefore, the sulfur atoms in the isomers 14, 15, and 16 are equatorial and trans to the olefinic substituents, whereas those in the isomers 14, 15, and 16 are axial and cis to the olefinic substituents.
Most of the 3-arylacroleins 12 used in the above reactions were prepared from the corresponding aryl aldehydes 11 stereoselectively by the homologation sequence shown in Chart 4. Thus, Horner-Wadsworth-Emmons reaction with phosphonoacetate 17 gave the esters 18; diisobutylaluminium hydride (DIBAL) reduction gave the allylic alcohols 19; and further oxidation gave 12. Most of the 5-aryl-2,4-pentadienals 13 were prepared from 11 in a similar manner using the phosphonocrotonate 20 via 21 and 22. The 3-arylacroleins 12D and 12E were prepared in one step from the corresponding aryl aldehydes 11D and 11E using (triphenylphosphoranylidene)acetaldehyde following a literature procedure.
12) The aldehyde 13E was prepared in a similar manner in one step from 11E using (triphenylphosphoranylidene)crotonaldehyde. 13) A cyclohexane analog 31 was prepared as shown in Chart 5 for comparing activities.
Antifungal Activity Since it is known that there is no good correlation between in vitro and in vivo activities of azole antifungal agents, 14) and we have experienced this discrepancy in the antifungal evaluation of the oxazolidine derivatives, 9f ) the compounds were evaluated in vivo using a murine model of systemic candidiasis. The results are summarized in Table 1 . In the model, a group of 10 mice were inoculated with fungi intravenously and the test compounds (16-20 mg/kg, per dose) were administered either orally (p.o.) or intraperitoneally (i.p.) 1, 4, and 24 h post infection. All the control (no drug) mice died within three days after infection whereas those that were given drugs survived substantially longer.
The structure-activity relationships were evaluated initially by comparing the in vivo activities of 9, 14A, 14C, and 14D, which have no olefinic carbon chain between the aryl and dioxane rings. The unsubstituted phenyl compound 9 exhibited a fair activity. Introducing an electron-withdrawing group such as a fluorine atom or a nitro group to the phenyl ring resulted in slight improvement in the survival rates.
We then fixed the aryl ring Ar to 2,4-difluorophenyl, and varied the length of the olefinic carbon chain between the dioxane and aryl rings (compounds 14C, 15C, and 16C). The compound 15C, with one olefinic double bond, showed a better in vivo activity against Candida albicans than the shortest compound 14C, and it was slightly active than the longer homolog 16C.
Accordingly, a number of the derivatives 15, which have one double bond, were prepared and tested. Compounds with an electron-donating substituent at the phenyl ring (e.g. the compound 15L) showed modest activity whereas those with an electron-withdrawing substituent such as a chlorine atom or a trifluoromethyl group (e.g. the compounds 15B, 15F, and 15G) showed good activity.
The 4-position seems to be the most suitable position in the phenyl ring for modification. As we can see by comparing 15A and 15K, introduction of a trifluoromethyl group at the 2-position, in addition to the fluorine atom at the 4-position, brought about only a small improvement in activity. The 3-trifluoromethyl derivatives 15G, 15H and 15J showed much higher activities than 15K, and the 4-trifluoromethyl derivatives 15F and 15I exhibited the highest activities.
The trifluoromethoxy derivatives 15N and 15O also showed high activities.
The cis (in terms of the stereochemistry on the 1,3-dioxane ring) isomers showed lower activities than the trans counterpart, as we can see by comparing 15B and 15B, 15F and 15F, and, 15Q and 15Q.
The activities of the pyridyl (15W, 15X, 15Y, and 15Z) and thienyl (15AA) analogs were lower than those of the phenyl analogs. However, the naphthyl ring analog 15AC exhibited excellent activity, comparable to that of the substituted phenyl compounds.
We then prepared the homologs 16, which have two double bonds. The relationship between the Ar groups and the antifungal activities paralleled that of the derivatives 15. Among the compounds, 16B, 16F, 16N, 16R, 16U and 16V showed high in vivo potency.
The cyclohexane ring analog 31 showed only fair activity, implying the importance of the 1,3-dioxane ring for antifungal activity.
Some of the compounds were evaluated further by a murine model of systemic aspergillosis. The results are summarized in Table 2 . In this model, a group of 10 mice were inoculated with either Aspergillus fumigatus or Aspergillus flavus intravenously, and the test compounds (20 mg/kg, per dose) were administered orally 1, 4, 24, 31, 48 and 55 h post infection.
Among the compounds tested, 15F, 15R, 15V, 15AC, 15AD, 16R, and 16V protected all mice for 14 d from both Aspergillus fumigatus and Aspergillus flavus.
In a preliminary toxicity study in rats (F344 strain, male, 5 weeks old, given drugs of 100 mg/kg/dose orally once daily for 14 d, each group consisting of five rats), all cases given 15F (a derivative with one double bond) died in the second week of the administration, but all rats given 16F, 16R and 16V (derivatives with two double bonds) survived without any apparent toxic symptoms. Among 16F, 16R and 16V, the compound 16R showed the lowest influence on adrenal glands and thyroid glands.
Finally, the compound 16R was tested in a murine infection model of Cryptococcus neoformans (Table 3 ). In the model, a group of 10 mice were inoculated with C. neoformans intravenously and the test compounds were administered orally once daily for 5 d. The results are summarized in 696 Vol. 48, No. 5
Chart 5 a) In vivo activity was determined in mice (each group consisted of ten male mice, ddY strain, 5 weeks old) infected systemically using an intravenous challenge of either 5ϫ10 6 conidia of Aspergillus fumigatus SANK 10569 or 3ϫ10 6 conidia of Aspergillus flavus SANK 18497. The triazole compounds (20 mg/kg/dose) were administered orally 1, 4, 24, 31, 48 and 55 h post infection. 0.5% Aqueous tragacantha pulverata (for 16E and 16V, 0.5% aqueous carboxymethyl cellulose sodium salt) was used as a vehicle for administration. b) Oxalic acid salts of the triazole derivatives except for 15E, 15AC, 15AD and 16R were prepared and tested. (8) 9a,b,e,10) (1.65 g, 6.57 mmol) and the thioester 7 (2.00 g, 8.40 mmol) in DMF (20 ml) at room temperature with stirring. The whole was then heated at 65°C for 2 h. After the mixture was cooled, it was diluted with AcOEt and washed with brine. The organic layer was dried and concentrated to give a crude oil. Chromatography (60 g, AcOEt : benzeneϭ1 : 5, v/v) afforded 9 (2.53 g, 91%) as a crystalline solid, which was used for the next reaction without further purification. An analytical sample, mp 58-60°C, was obtained by recrystallization from AcOEt-hexane. (253 mg, 0.57 mmol) in MeOH (3.5 ml) at room temperature. After the mixture was stirred at room temperature for 30 min, powdered NaHCO 3 (250 mg, 3.0 mmol) was added. The mixture was stirred at room temperature for 10 min and then filtered. The concentrated filtrate was chromatographed (5 g, MeOH-AcOEt, 1 : 9, v/v) to afford 10 (179 mg, 88%) as a colorless, viscous oil. 15) and 11AB 16) are known in the literature. The preparation of the other aryl aldehydes, 11M, 11R, 11U, 11V, 11X-11Z, 11AC, and 11AD is described below.
2-Methoxy-4-(trifluoromethyl)benzaldehyde (11M) Methyl 2-fluoro-4-(trifluoromethyl)benzoate (560 mg, 2.52 mmol) was treated with NaOMe (272 mg, 5.04 mmol) in MeOH (4.2 ml) at room temperature for 5 h. The mixture was acidified with HCl, concentrated, and diluted with AcOEt. The insoluble materials were removed by filtration. The filtrate was concentrated and the residue was chromatographed (21 g, AcOEt : hexaneϭ1 : 3, v/v) to afford methyl 2-methoxy-4-(trifluoromethyl)benzoate (333 mg, 56%) as an oil. A 1.5 M solution of DIBAL in toluene (5.9 ml, 8.9 mmol) was added to a stirred solution of methyl 2-methoxy-4-(trifluoromethyl)benzoate (1.04 g, 4.45 mmol) in toluene (10 ml) at 0°C. After the mixture was stirred at 0°C for 1 h, a saturated solution of NH 4 Cl was added, and the mixture was filtered through Celite. The precipitates were washed with toluene. The organic layer was separated and concentrated to give crude 2-methoxy-4-(trifluoromethyl)benzyl alcohol, 1 Ϫ1 : 1700. 4-(2,2,3,3-Tetrafluoropropoxy)benzaldehyde (11R) 4-Hydroxybenzaldehyde (5.3 g, 43 mmol) was added in small portions to a stirred suspension of NaH (55% mineral oil dispersion, 1.9 g, 43.5 mmol; washed with hexane) in N,N-dimethylacetamide (DMA) (25 ml) at 0°C. When hydrogen gas ceased to evolve, 2,2,3,3-tetrafluoropropyl p-toluenesulfonate (11.14 g, 39 mmol) was added, and the whole was stirred at 120°C for 2.3 h. After the solution was cooled, it was diluted with a mixture of benzene and hexane (ca. 1 : 1) and was washed with H 2 O. The organic layer was dried and concentrated to give 11R (8.85 g, 96%) as an air-sensitive oil, which was unsuitable for further purification. : 1701. 4-(Trifluoromethylthio)benzaldehyde (11U) A 1.0 M solution of DIBAL in toluene (9.8 ml, 9.8 mmol) was added to a stirred solution of 4-(trifluoromethyl)benzonitrile (1.0 g, 4.9 mmol) in toluene (10 ml) at Ϫ30°C. The mixture was worked up by adding a 10% aqueous solution of KHSO 4 . The product was extracted with toluene. The organic layer was concentrated, and the residual oil was chromographed (10 g, AcOEt : hexaneϭ1 : 5, v/v) to afford 11U (703 mg, 69%) as a crystalline solid, whose further purification was difficult owing to its air-sensitivity. 
4-(Trifluoromethylsulfonyl)benzaldehyde (11V)
A mixture of 4-(trifluoromethylthio)benzyl alcohol (500 mg, 2.4 mmol) and m-chloroperbenzoic acid (mCPBA, 70-75%, 1.48 g) in CHCl 3 (5 ml) was stirred at room temperature for 16 h and then at 70°C for 5 h. After the mixture was cooled, it was washed with an aqueous solution of Na 2 SO 3 . Solvents were removed in vacuo to afford crude 4-(trifluoromethylsulfonyl)benzyl alcohol (507 mg, 88%) as a crystalline mass, mp 40-42°C. 1 In a manner similar to that described above for the preparation of the alde-700 Vol. 48, No. 5 : 1700, 1373, 1218, 1141, 1074. 6-Chloropyridine-3-carbaldehyde (11X) Ethyl chloroformate (758 mg, 7.0 mmol) was added to a stirred solution of 6-chloro-3-nicotinic acid (1.0 g, 6.4 mmol) and Et 3 N (642 mg, 6.3 mmol) in tetrahydrofuran (THF) (12 ml) at Ϫ15°C. After the mixture was stirred for 15 min, a solution of NaBH 4 (648 mg, 17 mmol) in H 2 O (6 ml) was added. The whole was stirred at Ϫ15°C for 20 min, and then diluted with AcOEt (80 ml). The mixture was washed with brine and dried. Evaporation of the solvent and chromatographic purification (10 g, AcOEt : hexaneϭ3 : 2) of the residue afforded (6-chloro-3-pyridyl)methanol (785 mg, 86%) as needles, mp 63-65°C. A solution of dimethyl sulfoxide (DMSO) (1.02 g, 12.9 mmol) in CH 2 Cl 2 (1 ml) was added to a solution of oxalyl chloride (1.37 g, 10.8 mmol) in CH 2 Cl 2 (15 ml) at Ϫ78°C. After the mixture was stirred at Ϫ78°C for 10 min, a solution of (6-chloro-3-pyridyl)methanol (773 mg, 5.4 mmol) and Et 3 N (2.18 g, 21.5 mmol) in CH 2 Cl 2 (10 ml) was added. The mixture was allowed to warm to Ϫ15°C over 20 min, and then treated with a saturated aqueous solution of NH 4 Cl (25 ml). The product was extracted with AcOEt, and the organic layer was dried and concentrated to afford an oily residue, which was chromatographed (10 g, AcOEt : hexaneϭ1 : 4, v/v) to afford 11X (700 mg, 92%) as needles, mp 72-73°C, whose further purification was difficult owing to its air-sensitivity. 1 2-Chloropyridine-3-carbaldehyde (11Y) In a manner similar to that described above for the preparation of the aldehyde 11X, 2-chloro-3-nicotinic acid (1.0 g, 6.4 mmol) was reduced (ethyl chloroformate, NaBH 4 ) and then oxidized (DMSO, oxalyl chloride, Et 3 N) to afford, after chromatography, 11Y (664 mg, 74%) as a crude, crystalline solid, mp 37-41°C, whose further purification was difficult owing to its air-sensitivity. Tetrafluoropropanol was added slowly to a suspension of NaH (55% mineral oil dispersion, 840 mg, 19.3 mmol; washed with hexane) in DMF (40 ml) at 0°C. When hydrogen gas ceased to evolve, a solution of ethyl 6-chloro-3-niconinate (3.40 g, 18.3 mmol) in DMF (15 ml) was added over a period of 30 min. After the mixture was stirred at 0°C for 30 min, it was poured into ice water and the product was extracted with benzene. The extract was dried and the solvents were evaporated to give an oily residue, which was chromatographed (50 g, benzene : hexaneϭ2 : 3) to afford ethyl 6-(2,2,3,3-tetrafluoropropoxy)-3-nicotinate (4.42 g, 86%) as an oil. 1 6-Bromo-2-naphthaldehyde (11AC) A solution of methyl 6-bromo-2-naphtoate (2.50 g, 9.4 mmol) in THF (10 ml) was added to a stirred suspension of LiAlH 4 (537 mg, 14.1 mmol) in THF (15 ml) at 5-10°C. After the mixture was stirred at 5-10°C for 1 h, the reaction was worked up by adding a solution of NaOH (46 mg, 1.15 mmol) in H 2 O (1.6 ml). The insoluble materials were removed by filtration and the filtrate was concentrated to afford crude product of (6-bromo-2-naphthy)methanol (2.0 g, gross yieldϭ90%) as a powder, which was used for the next reaction without further purification.
In a manner similar to that described for the preparation of the aldehyde 11M, the crude product of (6-bromo-2-naphthyl)methanol ( 6-(2,2,3,3-Tetrahydropropoxy)-2-naphthaldehyde (11AD) Methyl 6-hydroxy-2-naphthoate (200 mg, 0.99 mmol) was added slowly to a stirred suspension of NaH (60% mineral oil dispersion, 39.6 mg, 0.99 mmol; washed with hexane) in DMA (2 ml) at 0°C. When hydrogen gas ceased to evolve, a solution of 2,2,3,3-tetrafluoropropyl p-toluenesulfonate (311 mg, 1.09 mmol) in DMA (1 ml) was added at the same temperature. The whole was stirred at 100°C for 2 h. After the solution was cooled, it was poured into ice water and the product was extracted with AcOEt. The organic layer was dried and concentrated to give an oily residue, which was chromatographed (5 g, AcOEt : hexaneϭ1 : 9, v/v) briefly to afford methyl 6-(2,2,3,3-tetrafluoropropoxy)-2-naphthoate (302 mg, gross yieldϭ96%) as a crude crystalline solid, which was used for the next reaction without further purification. 1 In a manner similar to that described for the preparation of the aldehyde 11M, the crude product of methyl 6-(2,2,3,3-tetrafluoropropoxy)-2-naphthoate (300 mg) was reduced (DIBAL) and then oxidized (MnO 2 ) to afford 11AD (210 g, 75%) as a colorless, air-sensitive solid. 1 (
E )-3-Aryl-2-propenals (12)
The aldehydes 12A-12C, 12F-12L, 12N-12T and 12V-12AD were prepared from the corresponding aryl aldehydes 11A-11C, 11F-11L, 11N-11T and 11V-11AD via a homologation sequence using triethyl phosphonoacetate (17) . As a typical example the preparation of 12F is described below. The aldehyde 12E was prepared from 11E according to the literature 12) using (triphenylphosphoranylidene)acetaldehyde. The aldehyde 12D was prepared from 11D in a similar manner as follows.
(E)-p-Nitrocinnamaldehyde (12D) A mixture of p-nitrobenzaldehyde (11D) (302 mg, 2.0 mmol), (triphenylphosphoranylidene)acetaldehyde (608 mg, 2.0 mmol) and toluene (5 ml) was refluxed for 100 min. The cooled mixture was concentrated in vacuo to give a brown mass, which was chromatographed on silica gel (20 g, AcOEt : hexaneϭ1 : 9, v/v) to afford a crude product of 12D. Recrystallizaion from benzene-hexane afforded a pure material of 12D (237 mg, 67%) as yellow needles, mp 105-110°C. 1 (E)-p-(Trifluoromethyl)cinnamaldehyde (12F) Triethyl phosphonoacetate (17) (4.63 g, 20.7 mmol) was added dropwise to a stirred suspension of NaH (55% mineral oil dispersion, 903 mg, 20.7 mmol; washed with hexane) in 1,2-dimethoxyethane (DME) (60 ml) at 0°C. After the mixture was stirred at 0°C for 15 min, 4-(trifluoromethyl)benzaldehyde (11F) (2.0 g, 11.5 mmol) was added. After the mixture had been stirred for 15 min, it was diluted with AcOEt and washed with H 2 O. The organic layer was dried and concentrated to give an oily residue, which was chromatographed on silica gel (50 g, AcOEt : hexaneϭ1 : 24, v/v) to afford ethyl (E)-p-(trifluoromethyl)cinnamate (18F) (2.75 g, 98%) as a crystalline mass, mp 31-32.5°C. aldehydes 13B, 13C, 13F,  13M, 13N, 13R, 13S, 13U, 13V, 13X, 13Z and 13AA were prepared from  the corresponding aryl aldehydes 11B, 11C, 11F, 11M, 11N, 11R, 11S, 11U , 11V, 11X, 11Z and 13AA via a homologation sequence using triethyl phosphonocrotonate (20). As a typical example, the preparation of 13F is described below. The aldehyde 13E was prepared from 11E using (triphenylphosphoranilidene)crotonaldehyde as follows.
4-[(1E,3E)-5-Oxo-1,3-pentadienyl]benzonitrile (13E)
A mixture of 4-formylbenzonitrile (11E) (13.1 g, 99 mmol), (triphenylphosphoranilidene)-crotonaldehyde 13) (40 g, 120 mmol) and CH 2 Cl 2 (200 ml) was stirred overnight. The mixture was concentrated in vacuo and the residual solid was chromatographed on silica gel (250 g) to remove polar byproducts. Elution with AcOEt afforded a crude product, which contained geometrical isomers, as judged by TLC. Then the mixture was dissolved in toluene (150 ml) and the solution was irradiated and refluxed for 12 h with a 300W tungsten lamp (visible light). The mixture was cooled and concentrated in vacuo to leave a solid residue, which was chromatographed on silica gel (1.2 kg). The fractions eluted with AcOEt-toluene (1 : 9, v/v) was concentrated and the crystals emerged were collected by filtration to give 13E (3.46 g, 19%) as light brown needles, mp 147-150°C. 1 
2E,4E )-5-[4-(Trifluoromethyl)phenyl]-2,4-pentadienal (13F)
Triethyl phosphonocrotonate (20) (25.9 g, 103 mmol) was added dropwise to a stirred suspension of NaH (55% mineral oil dispersion, 4.51 g, 103 mmol; washed with hexane) in DME (70 ml) at 0°C. After the mixture was stirred at 0°C for 15 min, 4-(trifluoromethyl)benzaldehyde (11F) (10.0 g, 57.4 mmol) was added slowly. After the mixture had been stirred for 10 min, it was poured into ice water and the product was extracted with AcOEt. The organic layer was dried and concentrated to give an oily residue, which was chromatographed (150 g, AcOEt : hexaneϭ3 : 47, v/v) to afford 21F (11.2 g, 72%) as an oil. A 1.5 M solution of DIBAL in toluene (27.7 ml, 41.6 mmol) was added to a stirred solution of 21F (5.31 g, 19.6 mmol) in toluene (50 ml) at 0°C. After the mixture was stirred at 0°C for 45 min, ice water were added in small portions with stirring. The mixture was diluted with AcOEt and filtered through Celite. The organic layer was separated and concentrated to give a solid residue, which was chromatographed (100 g, AcOEt : hexaneϭ1 : 4, v/v) and recrystallized from benzene-hexane to give 22F (2.47 g, 55%) as colorless needles, mp 72-75°C. 1 3R)-2-(2,4-Difluorophenyl)-3-[(trans-2-subustituted-1,3-dioxan-5-yl)thio]-1-(1H-1,2,4-triazol-1-yl)-2-butanols (14-16) and Their cis Isomers (14-16) These compounds were prepared by acetalization reaction between the alcohol 10 and the corresponding aldehydes 11, 12 and 13. The trans isomers 14-16 were predominantly produced and easily separated from the cis isomers 14-16 by silica gel column chromatography. The trans/cis ratio was between 5 : 1 and 10 : 1. As a typical example the preparation of 15F and 15F is described below. The spectral data are listed in Table 5 .
(
2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-[[trans-2-[(E )-2-[4-(trifluoromethyl)phenyl]vinyl]-1,3-dioxan-5-yl]thio]-2-butanol (15F)
Molecular sieves 4A (pellet, 57.6 g) was added to a stirred solution of the alcohol 10 (5.90 g, 16.4 mmol), aldehyde 12F (4.93 g, 24.6 mmol), and p-toluenesulfonic acid hydrate (4.69 g, 24.6 mmol) in CH 2 Cl 2 (200 ml) at room temperature. After the mixture was stirred at room temperature for 4 h, it was treated with a diluted aqueous solution of NaHCO 3 . The mixture was filtered, and the organic layer was dried and concentrated to give an oily residue, which was purified by column chromatography (250 g). Elution with AcOEt-hexane (1 : 24, v/v) gave the recovered aldehyde 12F (2.19 g ). Elution with AcOEt-hexane (1 : 1, v/v) afforded 15F (5.93 g, 67%) as colorless crystals, mp 73-75°C. Further elution with AcOEt-hexane (4 : 1, v/v) afforded the cis isomer 15F (753 mg, 8%) as a colorless oil.
8-(4-Chlorobenzylthio)-1,4-dioxaspiro[4.5]decane (24)
4-Chloro-atoluenethiol (430 mg, 2.7 mmol) was added to a stirred suspension of NaH (55% mineral oil dispersion, 106 mg, 2.4 mmol; washed with hexane) in DMF (4 ml) at 0°C. After the mixture was stirred at 0°C for 5 min, 1,4-dioxaspiro[4.5]decan-8-yl methanesulfonate 17) (23, 512 mg, 2.2 mmol) was added. The whole was heated at 50°C for 1 h. After the mixture was cooled, it was diluted with AcOEt and wshed with brine. The organic layer was dried over MgSO 4 and the solvents were removed in vacuo to leave an oily residue, which was purified by column chromatography (30 g). Elution with AcOEt-hexane (1 : 24, v/v) afforded 24 (438 mg, 68%) as an oil. 
4-(4-Chlorobenzylthio)cyclohexanone (25)
A 2 M solution of HCl (12.5 ml, 25 mmol) was added to a solution of 24 (11.0 g, 37 mmol) in a mixture of acetone (101 ml) and H 2 O (25 ml), and the whole was stirred at 50°C for 2 h. The cooled mixture was diluted with benzene and washed with brine. The organic layer was dried over MgSO 4 . Solvents were removed in vacuo to leave 25 (9.4 g, 100%) as an oil, which was used for the next reaction without further purification. 
1-(4-Chlorobenzylthio)-4-(methoxymethylene)cyclohexane (26)
A suspension of sodium hydride (55% mineral oil dispersion, 146 mg, 3.34 mmol; washed with hexane) in degassed DMSO (18 ml) was heated at 55°C for 2 h to obtain an almost clear solution of dimsyl sodium. (Methoxymethyl)triphenylphosphonium chloride (1.26 g, 3.67 mmol) was then added to the mixture at room temperature to obtain an orange-red solution. Then a solution of 25 (426 mg, 1.67 mmol) in DMSO (5 ml) was added at room temperature. The reaction was quenched by addition of H 2 O. The product was extracted with toluene. The organic layer was dried over MgSO 4 and concentrated to afford an oily residue, which was chromatographed on silica gel (20 g). Elution with CH 2 Cl 2 -hexane (1 : 4, v/v) afforded 26 (370 mg, 78%) as an oil. 5 mmol) , acetone (20 ml), and H 2 O (5 ml) was heated at 55°C for 2 h. Then the mixture was concentrated in vacuo at room temperature. The residue was taken up in AcOEt, and the extract was washed with brine and dried over Na 2 SO 4 . Evaporation of the solvent afforded an oily residue, which was chromatographed on silica gel (15 g). Elution with CH 2 Cl 2 -hexane (1 : 3, v/v) afforded a ca. 1 : 1 mixture of 27 and its cis isomer (865 mg, 95%). The isomeric ratio was determined by 1 H-NMR in CDCl 3 ; the benzylic protons of 27 appeared at d 3.73 as a singlet whereas those of the cis isomer appeared at d 3.67.
The above obtained mixture (865 mg) was treated, at room temperature for 2 h, with a solution of sodium methoxide prepared by dissolving sodium metal (23 mg, 1.0 mmol) in MeOH (15 ml). Acetic acid (0.2 ml) was then added and the mixture was concentrated in vacuo. The residue was taken up in AcOEt, and the extract was washed with brine and dried over MgSO 4 . Evaporation of the solvents afforded a solid residue, which was a ca. 4 : 1 mixture of 27 and its cis isomer, as indicated by 1 H-NMR. The residue was Table 5 . phenyl]-1,3-butadienyl]cyclohexane (28) A suspension of sodium hydride (55% mineral oil dispersion, 50 mg, 1.14 mmol) in DMSO (7 ml) was heated at 55°C for 2.5 h to obtain an almost clear solution of dimsyl sodium.
trans-1-(4-Chlorobenzylthio)-4-[(1E,3E )-4-[4-(trifluoromethyl)-
[(E)-( p-(Trifluoromethyl)cinnamyl)triphenylphosphonium chloride (607 mg, 1.26 mmol) was then added to the mixture at room temperature to obtain an orange solution. Then 27 (170 mg, 0.63 mmol) was added at room temperature. After the mixture was stirred at room temperature for 15 min, it was treated with H 2 O. Then it was diluted with toluene and washed successively with H 2 O and brine. The organic layer was dried over MgSO 4 and the solvent was removed in vacuo to afford an oily residue, which was chromatographed on silica gel (5 g). Elution with CH 2 Cl 2 -hexane (1 : 2, v/v) af- a) Recrystallization solvent: A, AcOEt; H, hexane; E, ether. b) Rotations were measured at 25°C. c) Chemical shifts are given with proton numbers, absorption patterns and coupling constants in Hz in parenthesis. d) The 1 H-NMR spectra of 14C and 15C were taken using a 60 MHz spectrometer in CDCl 3 . e) The 1 H-NMR spectrum of 15T was taken using a 60 MHz spectrometer in CDCl 3 containing D 2 O. f ) The [a] D value shows the optical rotation of the oxalic acid salt of 15Y. The melting point of the oxalic acid salt was difficult to measure because of the hygroscopicity. g) The 1 H-NMR spectrum of 16V was taken using a 400 MHz spectrometer in CDCl 3 .
